What is the management of bronchopleural fistula (BPF)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Bronchopleural Fistula (BPF)

Initial management of BPF should prioritize control of infection with antibiotics and adequate pleural drainage, followed by a stepwise approach that escalates from conservative management to bronchoscopic interventions, and finally to surgical repair only when less invasive methods fail or when dealing with large, early postoperative fistulas. 1, 2

Initial Assessment and Stabilization

Diagnostic Confirmation

  • CT chest with IV contrast is the diagnostic study of choice to confirm BPF, identify the fistulous tract, and evaluate underlying causes such as necrotizing pneumonia, abscess, or empyema 1
  • Direct CT signs include visualization of a fistulous tract between bronchus and pleural space 1
  • Indirect CT signs include air bubbles beneath the bronchial stump or suspected fistula site 1

Immediate Management Priorities

  • Control active infection with broad-spectrum antibiotics targeting anaerobic and aerobic organisms 1, 2
  • Ensure adequate drainage of the pleural space to prevent empyema progression 1, 2
  • Provide nutritional support, as BPF patients often have significant metabolic demands 2

Treatment Algorithm Based on Clinical Context

Conservative Management (First-Line for Small Fistulas and High-Risk Surgical Patients)

Conservative management combining tube drainage with postural drainage is effective for empyema-complicated post-lobectomy BPFs and should be attempted before surgical intervention in stable patients. 3

  • Proper chest tube drainage until disseminated pneumonia is controlled 3
  • Conduct pleural lavage followed by gradual transition from tube drainage to postural drainage 3
  • Chest tubes typically remain 7-114 days (mean 40 days) before removal 3
  • This approach achieved fistula healing in all 13 consecutive cases in one series without mortality 3

Bronchoscopic Interventions (For Small-to-Moderate Fistulas or Non-Surgical Candidates)

Bronchoscopic techniques serve as either definitive therapy for smaller BPFs or as a bridge to surgery in high-risk patients who require clinical optimization. 4, 2, 5

Available bronchoscopic options include:

  • Endobronchial valves (approved under humanitarian device exemption for prolonged air leaks) 4
  • Ethanol injection via EBUS-TBNA needle for directed submucosal injection leading to fistula closure 4
  • Fibrin glues, polyethylene glycol, autologous blood products, gel foam, or silver nitrate 4, 5
  • Amplatzer device (originally designed for atrial septal defects) 4
  • Coils and various sealants 5

Important caveat: No single bronchoscopic technique is universally applicable; therapeutic success has been variable across different methods 5

Surgical Management (For Large Fistulas or Failed Conservative/Bronchoscopic Treatment)

Surgical intervention is indicated for large BPFs, early postoperative fistulas, or when conservative management fails after 7 days without resolution of sepsis. 1

Indications for Surgery:

  • Large fistulas (particularly early postoperative) 1, 4
  • Persistent sepsis despite antibiotics, drainage, and fibrinolytics for >7 days 1
  • Prolonged sepsis, hemoptysis, or empyema complicating the fistula 1
  • BPF persisting >6 weeks with antibiotic treatment 1
  • Complex empyema with significant lung pathology (peel, trapped lung) 1
  • Pyopneumothorax with bronchopleural fistula 1

Surgical Options:

  • Percutaneous catheter drainage (PCD) for lung abscesses with BPF achieved complete resolution in 83% of cases, with 16% complication rate including spillage, bleeding, and empyema 1
  • Surgical resection (lobectomy or segmentectomy) required in approximately 10% of lung abscess cases 1
  • Video-assisted thoracoscopic surgery (VATS) for early-stage disease with less postoperative pain and shorter hospital stay 1
  • Open thoracotomy for advanced organized empyema where VATS has higher failure rates 1
  • Open window thoracostomy for persistent complex BPF requiring staged reconstruction 6

Special Considerations

Pediatric BPF Management

  • Avoid surgical intervention and chest tube placement via trocar in necrotizing pneumonia, as this increases risk of BPF 1
  • Most pediatric cases resolve with medical management (antibiotics, drainage, fibrinolytics) without surgery 1
  • Surgical consultation warranted if sepsis persists beyond 7 days despite optimal medical management 1

Risk Factors for BPF Development

  • Right-sided pneumonectomy carries higher risk than left-sided 4
  • Bi-lobectomy more likely to cause BPF than single lobectomy 4
  • Post-pneumonectomy incidence: 4.4-20% with mortality 27.2-71% 4
  • Post-lobectomy incidence: 0.5-1.5% 4

Complications to Monitor

  • Complications of percutaneous drainage include spillage of infection, bleeding, empyema, and paradoxically, new BPF formation 1
  • Secondary bacterial infection may develop during prolonged treatment 1
  • Persistent radiological abnormality in an asymptomatic, well child is NOT an indication for surgery 1

Stepwise Approach Summary

  1. Confirm diagnosis with CT chest with IV contrast 1
  2. Initiate antibiotics and ensure adequate pleural drainage 1, 2
  3. Attempt conservative management with tube/postural drainage for 7 days in stable patients 1, 3
  4. Consider bronchoscopic intervention for small-moderate fistulas or high-risk surgical patients 4, 5
  5. Proceed to surgical repair if conservative/bronchoscopic methods fail or for large, early postoperative fistulas 1
  6. Involve thoracic surgery early in decision-making, even if surgery is not immediately planned 1

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.